全文获取类型
收费全文 | 4035篇 |
免费 | 491篇 |
国内免费 | 134篇 |
出版年
2024年 | 14篇 |
2023年 | 78篇 |
2022年 | 112篇 |
2021年 | 208篇 |
2020年 | 192篇 |
2019年 | 257篇 |
2018年 | 221篇 |
2017年 | 161篇 |
2016年 | 103篇 |
2015年 | 155篇 |
2014年 | 291篇 |
2013年 | 393篇 |
2012年 | 180篇 |
2011年 | 202篇 |
2010年 | 180篇 |
2009年 | 156篇 |
2008年 | 177篇 |
2007年 | 186篇 |
2006年 | 159篇 |
2005年 | 138篇 |
2004年 | 113篇 |
2003年 | 104篇 |
2002年 | 102篇 |
2001年 | 90篇 |
2000年 | 60篇 |
1999年 | 68篇 |
1998年 | 58篇 |
1997年 | 57篇 |
1996年 | 43篇 |
1995年 | 33篇 |
1994年 | 58篇 |
1993年 | 33篇 |
1992年 | 28篇 |
1991年 | 30篇 |
1990年 | 14篇 |
1989年 | 15篇 |
1988年 | 22篇 |
1987年 | 15篇 |
1986年 | 17篇 |
1985年 | 25篇 |
1984年 | 24篇 |
1983年 | 11篇 |
1982年 | 14篇 |
1981年 | 8篇 |
1980年 | 9篇 |
1979年 | 9篇 |
1978年 | 11篇 |
1976年 | 7篇 |
1975年 | 6篇 |
1973年 | 4篇 |
排序方式: 共有4660条查询结果,搜索用时 15 毫秒
91.
摘要 目的:探讨龙血竭胶囊合九华膏对环状混合痔(RMH)术后患者创面愈合、血清炎性因子和免疫功能的影响。方法:选取2016年7月~2019年12月期间我院收治的RMH患者93例,根据随机数字表法分为对照组(n=46,马应龙麝香痔疮膏治疗)和研究组(n=47,龙血竭胶囊合九华膏治疗),比较两组患者疗效、创面愈合情况、不良反应、血清炎性因子和免疫功能。结果:治疗10 d后,研究组的临床总有效率为89.36%(42/47),高于对照组的71.74%(33/46)(P<0.05)。两组治疗10 d后创面渗液、水肿、疼痛、创面肉芽组织评分下降,创面面积减小,且研究组低于对照组(P<0.05)。两组治疗10 d后肿瘤坏死因子-α(TNF-α)、白介素-6(IL-6)、白介素-2(IL-2)均下降,且研究组低于对照组(P<0.05)。两组治疗10 d后免疫球蛋白G(IgG)、免疫球蛋白A(IgA)、免疫球蛋白M(IgM)均升高,且研究组高于对照组(P<0.05)。研究组并发症发生率低于对照组(P<0.05)。结论:RMH患者术后采用龙血竭胶囊合九华膏治疗,疗效较好,可有效促进创面愈合,减轻炎症反应,改善机体免疫功能,同时还可减少并发症发生率。 相似文献
92.
93.
Nicholas M. Wragg Diogo Mosqueira Lia Blokpeol‐Ferreras Andrew Capel Darren J. Player Neil R. W. Martin Yang Liu Mark P. Lewis 《Biotechnology journal》2020,15(1)
In vitro 3D tissue‐engineered (TE) structures have been shown to better represent in vivo tissue morphology and biochemical pathways than monolayer culture, and are less ethically questionable than animal models. However, to create systems with even greater relevance, multiple integrated tissue systems should be recreated in vitro. In the present study, the effects and conditions most suitable for the co‐culture of TE skeletal muscle and bone are investigated. High‐glucose Dulbecco's modified Eagle medium (HG‐DMEM) supplemented with 20% fetal bovine serum followed by HG‐DMEM with 2% horse serum is found to enable proliferation of both C2C12 muscle precursor cells and TE85 human osteosarcoma cells, fusion of C2C12s into myotubes, as well as an upregulation of RUNX2/CBFa1 in TE85s. Myotube formation is also evident within indirect contact monolayer cultures. Finally, in 3D co‐cultures, TE85 collagen/hydroxyapatite constructs have significantly greater expression of RUNX2/CBFa1 and osteocalcin/BGLAP in the presence of collagen‐based C2C12 skeletal muscle constructs; however, fusion within these constructs appears reduced. This work demonstrates the first report of the simultaneous co‐culture and differentiation of 3D TE skeletal muscle and bone, and represents a significant step toward a full in vitro 3D musculoskeletal junction model. 相似文献
94.
95.
96.
Albert Anastasio Marina Gergues Michael S Lebhar Pranela Rameshwar Joseph Fernandez-Moure 《World journal of stem cells》2020,12(11):1341-1353
The potential clinical and economic impact of mesenchymal stem cell (MSC) therapy is immense. MSCs act through multiple pathways: (1) as “trophic” cells, secreting various factors that are immunomodulatory, anti-inflammatory, anti-apoptotic, proangiogenic, proliferative, and chemoattractive; (2) in conjunction with cells native to the tissue they reside in to enhance differentiation of surrounding cells to facilitate tissue regrowth. Researchers have developed methods for the extraction and expansion of MSCs from animal and human tissues. While many sources of MSCs exist, including adipose tissue and iliac crest bone graft, compact bone (CB) MSCs have shown great potential for use in orthopaedic surgery. CB MSCs exert powerful immunomodulatory effects in addition to demonstrating excellent regenerative capacity for use in filling boney defects. CB MSCs have been shown to have enhanced response to hypoxic conditions when compared with other forms of MSCs. More work is needed to continue to characterize the potential applications for CB MSCs in orthopaedic trauma. 相似文献
97.
Mark Richard McNeill Chikako van Koten Stephen Latham Goldson 《Journal of Applied Entomology》2021,145(6):587-600
Listronotus bonariensis (Kuschel) is a pest of agriculturally important graminaceous species, with mining larvae that kill the stems of the host plants. In this study, larval populations were measured in spring and summer in irrigated dairy grassland comprising Lolium perenne L. (cv. Nui) with and without the endophyte Epichloë festucae var. lolii Latch, M.J. Chr. and Samuels and Poa annua L.. Larvae were extracted from tillers taken from the swards of these two grass species and extracted from turves, and L. bonariensis population densities were estimated from tiller and turf larval counts on a m−2 basis. Over the study period, the total number of larvae and larval densities extracted from turves was on average 2× greater than indicated from tillers. In most seasons, larval densities from turves were significantly higher than those from the tillers, though there was no correlation between tiller and turf larval densities. Mean head capsule widths of larvae emerging from turf samples showed significant seasonal effects compared with tillers, while mean head capsule widths of all four instars were significantly greater when extracted from tillers compared with turves. There was a significant endophyte effect on head capsule widths of larvae collected in summer, but the effect was not consistent across instars or source. Conversely, no significant endophyte effect on head capsule width was found in spring populations from either tillers or turves. This study shows that in irrigated dairy pasture, a high proportion of L. bonariensis larvae can live externally of tillers, presumably among the organic matter around the base of grasses in irrigated dairy pasture, and that density estimates based only on tiller populations will have significantly underestimated actual numbers. Having a precise indication of larval population densities is essential when developing life tables or determining economic damage threshold levels. 相似文献
98.
99.
ObjectivesStromal cell‐derived factor‐1 (SDF‐1) actively directs endogenous cell homing. Exendin‐4 (EX‐4) promotes stem cell osteogenic differentiation. Studies revealed that EX‐4 strengthened SDF‐1‐mediated stem cell migration. However, the effects of SDF‐1 and EX‐4 on periodontal ligament stem cells (PDLSCs) and bone regeneration have not been investigated. In this study, we aimed to evaluate the effects of SDF‐1/EX‐4 cotherapy on PDLSCs in vitro and periodontal bone regeneration in vivo.MethodsCell‐counting kit‐8 (CCK8), transwell assay, qRT‐PCR and western blot were used to determine the effects and mechanism of SDF‐1/EX‐4 cotherapy on PDLSCs in vitro. A rat periodontal bone defect model was developed to evaluate the effects of topical application of SDF‐1 and systemic injection of EX‐4 on endogenous cell recruitment, osteoclastogenesis and bone regeneration in vivo.ResultsSDF‐1/EX‐4 cotherapy had additive effects on PDLSC proliferation, migration, alkaline phosphatase (ALP) activity, mineral deposition and osteogenesis‐related gene expression compared to SDF‐1 or EX‐4 in vitro. Pretreatment with ERK inhibitor U0126 blocked SDF‐1/EX‐4 cotherapy induced ERK signal activation and PDLSC proliferation. SDF‐1/EX‐4 cotherapy significantly promoted new bone formation, recruited more CXCR4+ cells and CD90+/CD34‐ stromal cells to the defects, enhanced early‐stage osteoclastogenesis and osteogenesis‐related markers expression in regenerated bone compared to control, SDF‐1 or EX‐4 in vivo.ConclusionsSDF‐1/EX‐4 cotherapy synergistically regulated PDLSC activities, promoted periodontal bone formation, thereby providing a new strategy for periodontal bone regeneration. 相似文献
100.
Yuyi Chen Qiudong Yang Chunhua Lv Yue Chen Wenhua Zhao Wenlei Li Hongyu Chen Hua Wang Wen Sun Hua Yuan 《Cell proliferation》2021,54(2)
ObjectivesNLRP3 inflammasome is a critical part of the innate immune system and plays an important role in a variety of inflammatory diseases. However, the effects of NLRP3 inflammasome on periodontitis have not been fully studied.Materials and methodsWe used ligature‐induced periodontitis models of NLRP3 knockout mice (NLRP3KO) and their wildtype (WT) littermates to compare their alveolar bone phenotypes. We further used Lysm‐Cre/RosanTnG mouse to trace the changes of Lysm‐Cre+ osteoclast precursors in ligature‐induced periodontitis with or without MCC950 treatment. At last, we explored MCC950 as a potential drug for the treatment of periodontitis in vivo and in vitro.ResultsHere, we showed that the number of osteoclast precursors, osteoclast differentiation and alveolar bone loss were reduced in NLRP3KO mice compared with WT littermates, by using ligature‐induced periodontitis model. Next, MCC950, a specific inhibitor of the NLRP3 inflammasome, was used to inhibit osteoclast precursors differentiation into osteoclast. Further, we used Lysm‐Cre/RosanTnG mice to demonstrate that MCC950 decreases the number of Lysm‐Cre+ osteoclast precursors in ligature‐induced periodontitis. At last, treatment with MCC950 significantly suppressed alveolar bone loss with reduced IL‐1β activation and osteoclast differentiation in ligature‐induced periodontitis.ConclusionOur findings reveal that NLRP3 regulates alveolar bone loss in ligature‐induced periodontitis by promoting osteoclastic differentiation. 相似文献